The results showed that ANG (Figure 8A), EXO1 (Figure 8B), FBXO17 (Figure 8C), IGF2BP3 (Figure 8D), and NSUN7 (Figure 8E) displayed distinctly higher expression levels in glioma compared to controls (p < 0.05). This evidence concerns the gene NSUN7 and central nervous system cancer.